[The guideline for the diagnosis and treatment of marginal zone lymphoma in China (2025)] [0.03%]
中国边缘区淋巴瘤诊治指南（2025年版）
Hematological Oncology Committee of China Anti-Cancer Association;Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association;Lymphoma Expert Committee of Chinese Society of Clinical O
Hematological Oncology Committee of China Anti-Cancer Association;Lymphoid Disease Group
Marginal zone lymphoma (MZL) is an indolent B-cell lymphoma arising from marginal zone B cells within lymphoid follicles, accounting for approximately 5%-15% of non-Hodgkin lymphomas. MZL is characterized by diagnostic challenges and divers...
[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases] [0.03%]
嵌合抗原受体T细胞和嵌合抗原受体调节性T细胞治疗自身免疫病的研究进展
S A Pan,J Shi
S A Pan
Autoimmune diseases (AID) are disorders in which the immune system mistakenly attacks the body's own tissues. However, current immunosuppressive therapies seldom achieve durable, drug-free remission, indicating the urgent need for therapeut...
[Acquired factor ⅩⅢ deficiency with FⅩⅢ inhibitor secondary to rheumatoid arthritis: a case report] [0.03%]
获得性因子Ⅻ缺乏伴Ⅻ抑制物1例报告
B C Zhu,H C Cai,Y Zhang et al.
B C Zhu et al.
Y Miao,J Zhang,H Zhang et al.
Y Miao et al.
Intravascular large B-cell lymphoma (IVLBCL) is a rare large B-cell lymphoma subtype. We report a patient who presented with "recurrent fever and pancytopenia." A 64-year-old female patient had previously been diagnosed with Waldenstrom's m...
[Clinical characteristics and prognosis of 18 patients with plasmablastic lymphoma] [0.03%]
浆细胞淋巴瘤的临床特征及预后分析——附18例报告
S S Weng,Q Shi,W L Zhao et al.
S S Weng et al.
Plasmablastic lymphoma (PBL) is a rare, highly aggressive non-Hodgkin lymphoma subtype for which no standardized therapeutic regimen has been established in clinical practice. This study retrospectively analyzed 18 PBL cases at Shanghai Rui...
[Significance of the 50% hemolytic complement in hemolysis assessment and efficacy of eculizumab in patients with paroxysmal nocturnal hemoglobinuria] [0.03%]
50%补体溶血试验在溶血评估及依库珠单抗治疗阵发性睡眠性血红蛋白尿症中的意义
L Li,X Y Huang,X Q Ding et al.
L Li et al.
This study retrospectively analyzed data from 25 patients with paroxysmal nocturnal hemoglobinuria (PNH) admitted to Peking Union Medical College Hospital and Dongfang Hospital of Beijing University of Chinese Medicine from January 2023 to ...
[Clinical analysis of six eosinophilia cases with Löeffler endocarditis as the main clinical feature] [0.03%]
[6例以Loeffler心内膜炎为主要表现的嗜酸细胞性综合症临床分析]
Y N Ma,S N Chen,B Y Zhou et al.
Y N Ma et al.
To improve the understanding of Löeffler endocarditis, we retrospectively analyzed six patients with eosinophilia, predominantly characterized by Löeffler endocarditis, who were treated at the First Affiliated Hospital of Soochow Universi...
[Transformation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia into diffuse large B-cell lymphoma: five cases report and literature review] [0.03%]
[Waldenstrom巨球蛋白血症向弥漫性大B细胞淋巴瘤转化的临床分析及文献复习]
C Zhou,Q Y Zhang,S B Deng et al.
C Zhou et al.
Objective: To analyze the clinical features and prognosis of patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) transformed into diffuse large B-cell lymphoma (DLBCL) . Methods: This study retrospectively analy...
[Renal response and prognosis of newly diagnosed patients with multiple myeloma with renal impairment applying VRD and autologous hematopoietic stem cell transplantation] [0.03%]
肾损害的新诊断多发性骨髓瘤患者应用VRD方案和自体造血干细胞移植的肾脏反应及预后分析
X Y Wu,Y Huang,H M Shen et al.
X Y Wu et al.
Objective: To investigate the feasibility of the bortezomib, lenalidomide, and dexamethasone (VRD) regimen combined with autologous hematopoietic stem cell transplantation (auto-HSCT) in patients with multiple myeloma (MM) and renal impairm...
[Prognostic value of circulating plasma cell in newly diagnosed multiple myeloma treated with bortezomib, lenalidomide, and dexamethasone] [0.03%]
硼替佐米、来那度胺和地塞米松治疗新诊断多发性骨髓瘤患者循环浆细胞的预后价值
R R Liu,Y Yao,Y Y Jin et al.
R R Liu et al.
Objective: To investigate the prognostic value of circulating plasma cell (CPC) in patients with newly diagnosed multiple myeloma (NDMM) undergoing induction therapy with bortezomib, lenalidomide, and dexamethasone (VRD) regimen. Methods: T...